The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Well, it's been studied by thousands of labs, but the one that's most interesting, I think right now, is to see if a drug that activates AMPK extends human lifespan, slows down aging, and that's Nir Barzilai, my good friend down in New York, at Albert Einstein College of Medicine. - And the drug is metformin, which most people would know as a diabetes drug?
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Yeah, it's been used since the 1950s as the frontline medicine to bring down glucose levels in type two diabetics. And it is relatively safe as a drug goes.